A key advantage of the LMW-E-T1; p53+/− model characterized here is that the mice develop intermediate to high-grade adenocarcinomas in the parotid gland, independent of subtype and thus recapitulating the majority of SGCs observed clinically. This evidence concerns the gene TP53 and adenocarcinoma.